(1)
Meza Soto, E. A.; Gomez-Lujan, M.; Velasco Espinal, J. E.; Apolo Fajardo, I. A.; Mariscal, H.; Estrada García, M. N.; Trejo López, E.; Alvarado Echeona, K. The Role of GLP-1 Receptor Agonists (Ozempic and Mounjaro) As Secondary Therapy in Chronic Kidney Disease. Rev. Cienc. Multidiscip. SAGA 2025, 2 (3), 973-991. https://doi.org/10.63415/saga.v2i3.257.